Leadless Versus Transvenous Dual‐Chamber Pacemakers: Real‐World Evidence From AVEIR DR Coverage With Evidence Development Study
Despite a higher comorbidity burden, AVEIR DR LP had significantly fewer device-related complications, overall 6-month complications, and device reinterventions compared to TP, with similar overall 30-day complications, mortality, and heart failure hospitalizations.
Authors
- Anne M. Kroman (ORCID: https://orcid.org/0000-0001-6351-1260)
- M. Eyman Mortada (ORCID: https://orcid.org/0000-0002-1039-9110)
- Dilip Mathew
- Valay Parikh (ORCID: https://orcid.org/0000-0001-5213-5490)
- Monica Lo
- Anish K. Amin (ORCID: https://orcid.org/0000-0001-6432-1573)
- Stanislav Weiner
- Jennifer M. Joseph
- Marcin Kowalski
- Leonard Ganz
Institutions
- OhioHealth (US)
- Hofstra University (US)
- Medical University of South Carolina (US)
- Danaher (United States) (US)
- Staten Island University Hospital (US)
- Christus Health (US)
- Abbott (United States) (US)
- Aurora St. Luke's Medical Center (US)
- Sarasota Memorial Hospital (US)
- Arkansas Heart Hospital (US)
- Wake Forest University (US)
Publication Details
- Journal
- Journal of Cardiovascular Electrophysiology
- Published
- 2026-01-16
- DOI
- https://doi.org/10.1111/jce.70255
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00